Life Quality Study for PFAPA Patient

PFAPA Syndrome Clinical Trial

— PFAPA  

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02811705
• Other study ID #: P15/13_PFAPA
• Status: Completed
• Start date: July 2015
• Est. completion date: April 2017

Study information

• Verified date: February 2023
• Source: Versailles Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This cohort study aims to assess the quality of life (or welfare) related to the health of children and adolescents with an non genetics auto-inflammatory disease PFAPA or Marshall syndrome to compare it to children or adolescents with recurrent fever genetics of Familial Mediterranean fever (FMF) in order to improve their overall care.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: April 2017
• Est. primary completion date: December 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 2 Years to 18 Years

Eligibility

Inclusion Criteria:

• PFAPA syndrome patients or FMF patients

Exclusion Criteria:

• Participation refusal

Related Conditions & MeSH terms

• PFAPA Syndrome

Intervention

Other:
• Quality of life
Quality of life

Locations

Country	Name	City	State
France	Centre hospitalier de Versailles	Le Chesnay
France	CH de Bicètre	Paris

Sponsors (1)

Lead Sponsor	Collaborator
Versailles Hospital

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Compare quality of life from patients with PFAPA and FMF, reported by parents and by patients themselves		1 day
Secondary	Evaluate the fatigue status of patients through questionnaire PedsQL TM 3.0 multidimensional scale tiredness		1 day